
t2d.hugeamp.org to organize all the BIOCHEMICAL information is a massive project. understand the genetic is mind boggling. does the world need EVERYONE using up electricity & creating heat to find answers? do we need to all duplicate same work?
Eva D B Fain, BSN MPH RN CDE, CHES
57.7K posts

@espacetimeNOT
35 year focus on metabolism across cultures & thru time. I prefer private networks & I use LinkedIn & other social media to ascertain your identity.

t2d.hugeamp.org to organize all the BIOCHEMICAL information is a massive project. understand the genetic is mind boggling. does the world need EVERYONE using up electricity & creating heat to find answers? do we need to all duplicate same work?

Do highly tasty (“hyper-palatable”) foods make us overeat? Must food manufacturers market bland products to protect the public from obesity? My thoughts in a Perspective in PLoS Medicine. 👉Open access at this link: journals.plos.org/plosmedicine/a…






“In the garden, the enemy is everything: the aphids, the weather, time...You pour yourself into it, care so much, & see up close so much birth & growth & beauty & danger & triumph—& then everything dies anyway, right? But u just keep doing it. What a great metaphor!” ~@ANNELAMOTT





“I have an index card here on which is written, ‘Six years later, the memory of the raw fish cubes continued to haunt her,’ which I thought might make a great transitional line. But I have so far not found a place for it. You are welcome to use it if you can.” ~@ANNELAMOTT



Or, as we used to say: correlation does not imply causation.


Orforglipron has one of the best weight loss data among all the oral GLP1 receptor agonism based medicines It can cause on an average 9% weight loss from baseline 24-36mg/d daily oral dose is best suited dose range for use A big thanks to all the authors & Wiley for recognising our work, one of the first meta-analysis ever published on the clinical efficacy & safety of orforglipron use Full text at: onlinelibrary.wiley.com/doi/10.1002/os… @abm_kamrul @IndiaESI @Rssdi_official @WileyLifeSci @ObesitySociety @WorldObesity @ChildObesity_jn @RCSI_Obesity @CD8ProbSolvers7 @OHA_updates @UK_ASO @ObesityAction @ObesityCan

@caloriesproper2 make candles great again

the advent and widespread acceptance of LED lights was an extinction-level event

🐭New Nature Metabolism study (2026) identifies a novel immune-metabolic pathway by which irisin which is an exercise-induced myokine. It reduces obesity and insulin resistance in mice.🐭 🏃 Irisin is released during exercise, cleaved from FNDC5 in muscle 📈 Irisin overexpression in HFD-fed mice: reduced obesity + improved insulin sensitivity 🟢 Irisin increases IL-33 in white adipose tissue 🛡️ IL-33 preserves ST2+ regulatory T cells in adipose tissue 🔬 Adipose regulatory T cells suppress inflammation → metabolic protection Exercise reshapes the immune microenvironment of fat tissue. IL-33/T cell signaling may be a new therapeutic target for obesity-related insulin resistance. This adds a bit more basic science to understanding obesity and metabolic disease as fundamentally an issue of immune dysregulation. 🏁 doi.org/10.1038/s42255…


🐭New Nature Metabolism study (2026) identifies a novel immune-metabolic pathway by which irisin which is an exercise-induced myokine. It reduces obesity and insulin resistance in mice.🐭 🏃 Irisin is released during exercise, cleaved from FNDC5 in muscle 📈 Irisin overexpression in HFD-fed mice: reduced obesity + improved insulin sensitivity 🟢 Irisin increases IL-33 in white adipose tissue 🛡️ IL-33 preserves ST2+ regulatory T cells in adipose tissue 🔬 Adipose regulatory T cells suppress inflammation → metabolic protection Exercise reshapes the immune microenvironment of fat tissue. IL-33/T cell signaling may be a new therapeutic target for obesity-related insulin resistance. This adds a bit more basic science to understanding obesity and metabolic disease as fundamentally an issue of immune dysregulation. 🏁 doi.org/10.1038/s42255…